Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non …

The gut microbiota has been linked to the emergence of obesity, metabolic syndrome and
the onset of type 2 diabetes through decreased glucose tolerance and insulin resistance …

NAFLD is currently the main cause of chronic liver disease in developed countries, and the
number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to …

Objective To systematically review the effect of oral intake of bacterial probiotics on 15
variables related to obesity, diabetes and non-alcoholic fatty liver disease. Design …

Animal studies indicate that the composition of gut microbiota may be involved in the
progression of insulin resistance to type 2 diabetes. Probiotics and/or prebiotics could be a …

A systematic review and meta‐analysis of randomized controlled trials was conducted to
examine the effects of probiotic supplementation on body weight, body mass index (BMI), fat …

The worldwide prevalence of obesity more than doubled between 1980 and 2014. The
obesity pandemic is tightly linked to an increase in energy availability, sedentariness and …

Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress liver injury that is closely
related to obesity, insulin resistance, type 2 diabetes, atherosclerosis, and metabolic …

Background Preclinical evidence suggests that modulation of the gut microbiome could
represent a new therapeutic target in nonalcoholic fatty liver disease (NAFLD). Objectives …

Table 3 Nomenclature for microorganisms 3 Table 4 Examples of probiotic strains in
products 4 Table 5 Information on suppliers of probiotics and prebiotics 5 Table 6 Human …